NDC 0641-6044-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6044
- Requested NDC
- 0641-6044-01
- Package NDCs from labels
- 0641-6044-01, 0641-6044-25
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Injection, USP | REMEDYREPACK INC. | 2024-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - TYA Pharmaceuticals | TYA Pharmaceuticals | 2011-11-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6044-01 | Lorazepam | 1 mL in 1 VIAL | INJECTION | 1 | 10 | |
| 0641-6044-25 | Lorazepam | 25 in 1 CARTON | INJECTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6044-01 | ML - Milliliter | 0641-6044 | 9c10d57c-be4d-4e5c-bd04-680c477d6ef8 | 1 | 2012-07-24 |
| 0641-6044-25 | ML - Milliliter | 0641-6044 | 6e34d5a1-9495-43ce-a1cb-9f6626a83af7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | RedPharm Drug, Inc. | 891b2c10-942f-0e4d-e053-2995a90af028 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PharmPak, Inc. | b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Systane Complete PF | PROPYLENE GLYCOL EMULSION | Alcon Laboratories, Inc. | 798ffdde-1dba-4a3f-a0b6-937f9e958cca | 2025-11-03 | Warnings | 6DC9Q167V3 |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | 6DC9Q167V3 |
| Walgreens Ultra Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4533-2061-e063-6394a90a6e73 | 2025-10-17 | Warnings | 6DC9Q167V3 B697894SGQ |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | American Health Packaging | 45e31a87-a8db-4dda-b94b-83535b62e8e2 | 2025-09-14 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane COMPLETE | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 2df0de02-a3e2-471a-9e10-040c3fba75fe | 2025-08-08 | Warnings | 6DC9Q167V3 |
| Systane Balance | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | c7b1a03a-a5f2-409e-a34a-d6f166671de5 | 2025-08-07 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Lorazepam | LORAZEPAM | Rising Pharma Holdings, Inc. | 386255e2-65aa-48ce-9eb1-246f1493cc14 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.